XMT-1660: A Phase 1b trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers

被引：0
|
作者：
Hamilton, Erika [1 ]
Spira, Alexander [2 ]
Adams, Sylvia [3 ]
Abuhadra, Nour [4 ]
Giordano, Antonio [5 ]
Parajuli, Ritesh [6 ]
Han, Hyo [7 ]
Weise, Amy [8 ]
Marchesani, Aubri [9 ]
Josephs, Kate [9 ]
Chaudhry, Arvind [10 ]
Kalinsky, Kevin [11 ]
机构：
[1] Sarah Cannon Res Inst, Nashville, TN USA
[2] NEXT Oncol, Fairfax, VA USA
[3] NYU Langhone, Perlmutter Canc Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Dana Farber Canc Inst, Boston, MA USA
[6] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[8] Henry Ford Canc Inst, Detroit, MI USA
[9] Mersana Therapeut, Cambridge, MA USA
[10] Summit Canc Ctr, Spokane, WA USA
[11] Winship Canc Inst, Atlanta, GA USA
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.159
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1250
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [41] Development and functional characterization of NC762, a novel therapeutic antibody targeting B7-H4, for the treatment of malignancies.
    Archer, Kristina
    Ceradoy, Justine
    Coupet, Tiffany
    Bosiacki, Jason
    Song, Chang
    Weiss, Ido
    Niu, Sue
    Obot, Tete
    Xu, Jinglin
    O'Neill, Tom
    Ferrell, Alison
    Abukharma, Hasan
    Cusumano, Zac
    Flies, Dallas
    Langermann, Sol
    Liu, Linda N.
    CANCER RESEARCH, 2021, 81 (13)
  • [42] Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas
    Niu, Na
    Shen, Weiwei
    Zhong, Yanping
    Bast, Robert C., Jr.
    Jazaeri, Amir
    Sood, Anil K.
    Liu, Jinsong
    HUMAN PATHOLOGY, 2021, 113 : 20 - 27
  • [43] Phase 1 dose escalation study of MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors.
    Jang, Sekwon
    Powderly, John D.
    Spira, Alexander I.
    Bakkacha, Ouiam
    Loo, Deryk
    Bohac, Gerry C.
    Sharma, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
    Ling Wang
    Chao Yang
    Xin-bo Liu
    Li Wang
    Fu-biao Kang
    Cancer Cell International, 18
  • [45] B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
    Wang, Ling
    Yang, Chao
    Liu, Xin-bo
    Wang, Li
    Kang, Fu-biao
    CANCER CELL INTERNATIONAL, 2018, 18
  • [46] Phase 1 dose escalation of XMT-1522, a novel HER2-targeting antibody-drug conjugate (ADC), in patients (pts) with HER2-expressing breast, lung and gastric tumors.
    Hamilton, Erika Paige
    Barve, Minal A.
    Bardia, Aditya
    Beeram, Muralidhar
    Bendell, Johanna C.
    Mosher, Rebecca
    Hailman, Eric
    Bergstrom, Donald Alan
    Burris, Howard A.
    Soliman, Hatem Hussein
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] A phase 1 dose escalation/expansion study of GSK5764227 (GSK'227), a B7-homolog 3 (B7-H3) protein targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors, including gastrointestinal (GI) cancers
    Saif, Wasif M.
    Cassier, Philippe Alexandre
    Curigliano, Giuseppe
    Daniele, Gennaro
    Hilton, John Frederick
    Koganemaru, Shigehiro
    Kowalyszyn, Ruben
    Lorusso, Patricia
    Moreno, Victor
    Olmedo Garcia, Maria Eugenia
    Perroud, Herman Andres
    Symeonides, Stefan N.
    Yamamoto, Noboru
    Aziez, Amine
    Anjum, Rana
    Lamacchia, John
    Sembhi, Harjeet
    Ratia, Nirav
    Italiano, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS847 - TPS847
  • [48] Preclinical development of a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
    Son, Thomas
    Scribner, Juniper A.
    Hooley, Jeff
    Chiechi, Michael
    Li, Pam
    Hotaling, Timothy E.
    De Costa, Anushka
    Chen, Yan
    Chen, Francine
    Barat, Bhaswati
    Ciccarone, Valentina
    Gaynutdinov, Timur
    Tamura, James
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2017, 77
  • [49] ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3-targeting antibody-drug conjugate, in patients with advanced solid tumor
    Wang, Jie
    Duan, Jianchun
    Xing, Ligang
    Sun, Yuping
    Guo, Wei
    Wang, Haiying
    Chen, Jianhua
    Han, Liang
    Liu, Baogang
    Wang, Qiming
    Hu, Ying
    Wei, Hongying
    Li, Chuan
    Huang, Qiqi
    Dong, Yiwei
    Wu, Qiong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer
    Altan, Mehmet
    Kidwell, Kelley M.
    Pelekanou, Vasiliki
    Carvajal-Hausdorf, Daniel E.
    Schalper, Kurt A.
    Toki, Maria, I
    Thomas, Dafydd G.
    Sabel, Michael S.
    Hayes, Daniel F.
    Rimm, David L.
    NPJ BREAST CANCER, 2018, 4
12345